In the U.S., lower HPV vaccination rates, uneven access to screening and delayed adoption of HPV-based testing have contributed to preventable illness and death. These are not inevitable outcomes; ...

Gilead beats Q4 estimates on strong HIV and Liver Disease portfolio performance, but 2026 guidance tempers sentiment despite ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

LONDON, Feb 13 (Reuters) - Vaccines are a matter of national security, a leading global health figure said this week, warning ...

Because measles is so contagious, experts say that vaccination rates need to be above about 95 percent to stem the spread of ...

As population immunity continues to grow, understanding how immune responses influence both disease outcomes and viral evolution has become increasingly important.